Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Translational Lung Cancer Research|March 15, 2021
The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative reviewYu Liu, Peixin Chen, Hao Wang, et al.
The Journal of International Medical Research|October 12, 2018
Risk factors for nicotine dependence in Chinese patients with lung cancerFen Gu, Yayi He, Yanjun Mao, et al.
Cancer Science|June 15, 2016
Lymphocyte-activation gene-3, an important immune checkpoint in cancerYayi He, Christopher J Rivard, Leslie Rozeboom, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 10, 2017
PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating LymphocytesYayi He, Leslie Rozeboom, Christopher J Rivard, et al.
Oncoimmunology|July 22, 2021
An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)Haoyue Guo, Binglei Li, Li Diao, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Pyroptosis: A promising target for lung cancer therapyWensheng Zhou, Lishu Zhao, Hao Wang, et al.
Analytical Chemistry|February 21, 2026
One Blow To Obtain Integrated Information on Metals, NO, and Metabolites in Breath Gas by Mass SpectrometryBotong Liu, Ling Mao, Yayi He, et al.
Immunity, Inflammation and Disease|October 5, 2020
MICA polymorphisms associated with antithyroid drug-induced agranulocytosis in the Chinese Han populationXiaojuan Gong, Pu Chen, Pan Ma, et al.
Translational Lung Cancer Research|May 19, 2020
Anti PD-1 monoclonal antibody induced autoimmune diabetes mellitus: a case report and brief reviewWei Li, Hao Wang, Bin Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
MHC class II expression in lung cancerYayi He, Leslie Rozeboom, Christopher J Rivard, et al.
Pageof 16